World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02330302
Date of registration: 31/12/2014
Prospective Registration: No
Primary sponsor: Changi General Hospital
Public title: Single Shot Fascia Iliaca Block vs Femoral Nerve Block for Analgesia for Surgical Fixation of Hip Fractures
Scientific title: A Randomized Controlled Trial Comparing Single Shot Fascia Iliaca Block With Femoral Nerve Block for Analgesia Following Surgical Fixation of Hip Fractures
Date of first enrolment: August 2014
Target sample size: 30
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02330302
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Singapore
Contacts
Name:     Yean Chin Lim, MBBS, MMed
Address: 
Telephone:
Email:
Affiliation:  Changi General Hospital
Key inclusion & exclusion criteria

Inclusion Criteria:

- Patients scheduled for surgical fixation of hip fracture

- Patients with isolated inter-trochantric fracture

- American Society of Anesthesiologists (ASA) physical status 1 to 3

- Patients who are able to give their own consent

Exclusion Criteria:

- Patients unable to give consent or inability to communicate/ cooperate

- Patients with regular consumption of strong opioids (morphine, oxycodone) or steroids

- Patients with allergy to local anaesthetics or any drugs included in the study

- Patients with contraindications to spinal anaesthesia such as coagulation disorders/
thrombocytopenia and local infection at site of injection



Age minimum: N/A
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Hip Fracture
Intervention(s)
Drug: Ropivacaine
Primary Outcome(s)
Pain scores [Time Frame: up to 24 hours]
Secondary Outcome(s)
opioid requirement/consumption [Time Frame: for first 24 hrs (including intra operatively) following intervention]
Secondary ID(s)
2014/453/D
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history